RxDoctor Payments Data

Gina Kicos, APRN

Family · Canton, OHNPI 1073952685

Payments from drug & device makers

$3,977in general payments, 2019–2025

Across 99 payments — averaging $40.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Daiichi Sankyo Inc.$170
  • Johnson & Johnson$155
  • Ardelyx, Inc.$94
  • Takeda Pharmaceuticals U.S.A., Inc.$82
  • QOL Medical, LLC$63
  • plus $216 from 7 others

What the payments were for

  • Speaking & faculty fees$2,43861%
  • Food & beverage$1,45537%
  • Education$842%

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,977 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$9,623
Medicare patients
39
Services billed
160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide89$83,608
JardianceEmpagliflozin50$48,594
TrulicityDulaglutide28$43,409
EliquisApixaban40$31,858
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$27,430
XareltoRivaroxaban38$26,712
OzempicSemaglutide20$26,111
Spiriva RespimatTiotropium Bromide20$21,102
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr25$14,816
Tresiba Flextouch U-100Insulin Degludec18$8,282
MovantikNaloxegol Oxalate13$5,497
SymbicortBudesonide/Formoterol Fumarate20$5,035
BrilintaTicagrelor11$4,981
Albuterol Sulfate HfaAlbuterol Sulfate216$4,950
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$4,359

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$3,198$83,60889 claims
Lilly USA, LLCTrulicity$36$43,40928 claims
Johnson & JohnsonXarelto$155$26,71238 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.

Other family in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →